MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    How do cognitive profiles differ in patients with Parkinson’s disease with cognitive decline in comparison to patients remaining cognitively stable? Preliminary results of a 3 years follow-up study

    A. Meyer, U. Gschwandtner, V. Cozac, F. Hatz, P. Fuhr (Basel, Switzerland)

    Objective: (1) To ascertain the evolution of neuropsychological profile of PD patients with stable cognition (non-converter) in comparison to PD patients with a decline (converters)…
  • 2016 International Congress

    Attention and dopamine: Increased distractibility in Parkinson’s disease

    C. Warden, S. YorkWilliams, N. Ahn, D. Everling, K.L. Poston (Stanford, CA, USA)

    Objective: To determine the interactions between dopamine, Working Memory(WM) and Attentional Control(AC) in Parkinson's disease(PD) patients. Background: WM impairment is common in PD. Studies have…
  • 2016 International Congress

    Does repetitive transcranial magnetic stimulation (rTMS) affect cognitive function in Parkinson’s disease by modulating high-frequency brain oscillations: A magnetoencephalography (MEG) study

    I. Buard, J. Shattuck, B.M. Kluger (Aurora, CO, USA)

    Objective: To better understand the mechanisms of how repetitive transcranial magnetic stimulation (rTMS) may improve cognitive function in Parkinson's disease (PD). Background: Cognitive dysfunction and…
  • 2016 International Congress

    Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination

    M.J. Sollman, J.G. Hesse, B.C. Sachs, J.F. Cook (Winston-Salem, NC, USA)

    Objective: To evaluate utility of the DRS-II Total Score for stratifying cognitive status in PD patients without frank cognitive impairment. Background: The DRS-II, a screening…
  • 2016 International Congress

    Consolidation of learning and memory in Parkinson’s disease

    M.E. Sharp, K. Duncan, K. Foerde, R. Kahane, D. Shohamy (New York City, NY, USA)

    Objective: To determine if Parkinson's disease causes an impairment in the ability to consolidate learning into long-term memory and to determine if this deficit is…
  • 2016 International Congress

    Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia

    N.G. Sokhibnazarov, F.K. Shermukhamedova (Tashkent, Uzbekistan)

    Objective: Aim of this study was to identify the degree of cognitive dysfunction in patients with subcortical Parkinsonian dementia, during the neuroprotective therapy. Background: Parkinson's…
  • 2016 International Congress

    Cognitive complaint in Parkinson’s disease patients with normal cognition

    R.F. Purri, L. Brennan, J. Rick, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J.E. Duda, J.F. Morley, R.S. Akhtar, J.Q. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To characterize cognitively normal PD patients who endorse cognitive complaint, and to assess their cognitive performance over time. Background: PD patients are at a…
  • 2016 International Congress

    Impaired cube copy on the MOCA indicates worse performance in several cognitive domains in Parkinson´s disease

    C. Gasca-Salas, M. Cohn, J.A. Pineda, J.A. Obeso (Madrid, Spain)

    Objective: We aimed to identify if an impairment of the cube copy of the Montreal Cognitive assessment (MoCA) was associated with worse cognitive status in…
  • 2016 International Congress

    Construct validity of Moca test in a sample of patients with Parkinson´s disease in Bogotá and Cali – Colombia

    B.E. Muñoz, O. Bernal, A. Castillo, J.L. Orozco (Cali, Colombia)

    Objective: To evaluate of construct validity for a sample of patients with PD in Bogotá and Cali - Colombia. Background: Parkinson´s disease (PD) is a…
  • 2016 International Congress

    The alterations in behavioral memory for prolongation disease duration in patients with Parkinson’s disease

    M. Saruwatari, Y. Kobayashi, A. Kumon, K. Hasegawa (Sagamihara, Japan)

    Objective: Aim of this study is to assess the alterations in daily behavioral memory for prolongation of disease duration in PD. Background: We are continuing…
  • « Previous Page
  • 1
  • …
  • 1668
  • 1669
  • 1670
  • 1671
  • 1672
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley